Singapore: China Cord Blood Corporation repurchased an aggregate of 2,191,412 ordinary shares for a total consideration ...
Singapore: 3SBio, a leading China-based biotechnology company focused on researching, developing, manufacturing and mark...
Singapore: China Botanic Pharmaceutical, a developer, manufacturer and distributor of botanical products, bio-pharmaceut...
Shenzhen Neptunus Bioengineering, engaged in manufacturing and distribution of pharmaceuticals in China, is currently pr...
Singapore: Mindray Medical, a leading developer, manufacturer and marketer of medical devices worldwide, published its s...
Singapore: The training of next-generation clinical investigators in China is at the core of a new collaboration between...
Singapore: Simcere Pharma has agreed to sell its 99.99 percent stake in Jilin Boda Pharma for $65 million. The company f...
Singapore: Days after British drug maker GlaxoSmithKline faced allegations of a wide-ranging bribery scandal in China, t...
Singapore: Research-based pharmaceutical company Boehringer Ingelheim and Taizhou China Medical City in China have signe...
Singapore: A new report by the UBM Canon Medtech World team, has highlighted that the Asia Pacific medical technology ma...
Singapore: Life Technologies has completed its manufacturing facility in Beijing where the most advanced DNA testing sol...
Singapore: X-Body Biosciences entered into an exclusive alliance with Jiangsu Hengrui Medicine, in which Hengrui will de...
Singapore: QIAGEN announced an agreement with Lepu Medical Technology, Beijing, a leading medical device company in Chi...
Singapore: The pharmaceuticals industry in the Asia Pacific is thriving on the back of escalating population and increa...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to...
Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscienc...